Rapid Micro Biosystems (NASDAQ:RPID) Issues Earnings Results

Rapid Micro Biosystems (NASDAQ:RPID) posted its earnings results on Friday. The company reported ($0.26) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.26), RTT News reports. The company had revenue of $7.60 million for the quarter, compared to analysts’ expectations of $6.30 million. Rapid Micro Biosystems had a negative return on equity of 45.23% and a negative net margin of 204.22%. During the same period last year, the business posted ($0.31) earnings per share. Rapid Micro Biosystems updated its FY 2024 guidance to EPS.

Rapid Micro Biosystems Stock Performance

RPID stock opened at $1.10 on Friday. The stock has a market capitalization of $47.20 million, a price-to-earnings ratio of -0.94 and a beta of 1.07. Rapid Micro Biosystems has a 1 year low of $0.58 and a 1 year high of $1.19. The stock’s fifty day moving average is $0.89 and its two-hundred day moving average is $0.82.

Insider Buying and Selling at Rapid Micro Biosystems

In related news, Director Kirk Malloy bought 50,000 shares of the business’s stock in a transaction on Thursday, August 8th. The shares were bought at an average cost of $0.91 per share, for a total transaction of $45,500.00. Following the completion of the purchase, the director now owns 64,300 shares of the company’s stock, valued at $58,513. This represents a 300.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, Director Kirk Malloy acquired 50,000 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The shares were acquired at an average cost of $0.91 per share, for a total transaction of $45,500.00. Following the completion of the purchase, the director now directly owns 64,300 shares in the company, valued at $58,513. This trade represents a 300.00 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Richard S. Kollender acquired 65,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The shares were bought at an average price of $0.77 per share, for a total transaction of $50,050.00. Following the completion of the purchase, the director now owns 96,718 shares of the company’s stock, valued at approximately $74,472.86. This represents a 200.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 175,000 shares of company stock worth $141,850. 30.40% of the stock is owned by insiders.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.